sameAs
Few and far between: how HIV may be evading antibody avidityCrystal structure of the HSV-1 Fc receptor bound to Fc reveals a mechanism for antibody bipolar bridging.Crystal structure of LIR-2 (ILT4) at 1.8 A: differences from LIR-1 (ILT2) in regions implicated in the binding of the Human Cytomegalovirus class I MHC homolog UL18.Neogenin interacts with hemojuvelin through its two membrane-proximal fibronectin type III domainsIncreasing the potency and breadth of an HIV antibody by using structure-based rational designNeogenin-mediated hemojuvelin shedding occurs after hemojuvelin traffics to the plasma membraneStructure of a pheromone receptor-associated MHC molecule with an open and empty grooveCharacterization of Antibody Bipolar Bridging Mediated by the Human Cytomegalovirus Fc Receptor gp68The herpes virus Fc receptor gE-gI mediates antibody bipolar bridging to clear viral antigens from the cell surfaceElectron tomography of HIV-1 infection in gut-associated lymphoid tissueRetroviruses use CD169-mediated trans-infection of permissive lymphocytes to establish infection.Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-FcCrystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptorStructural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 DonorsThe structure of a polyQ-anti-polyQ complex reveals binding according to a linear lattice modelExtension of Drosophila melanogaster life span with a GPCR peptide inhibitorThe Crystal Structure of CHIR-AB1: A Primordial Avian Classical Fc ReceptorStructure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptorCrystal structure of TNFα complexed with a poxvirus MHC-related TNF binding proteinStructure of a clade C HIV-1 gp120 bound to CD4 and CD4-induced antibody reveals anti-CD4 polyreactivityCrystal structure of a hemojuvelin-binding fragment of neogenin at 1.8ÅSequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 BindingDesigned oligomers of cyanovirin-N show enhanced HIV neutralizationComplex-type N-glycan recognition by potent broadly neutralizing HIV antibodiesStructural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibodySomatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 NeutralizationRestricting HIV-1 pathways for escape using rationally designed anti–HIV-1 antibodiesStructural Basis for Enhanced HIV-1 Neutralization by a Dimeric Immunoglobulin G Form of the Glycan-Recognizing Antibody 2G12Antibody 8ANC195 Reveals a Site of Broad Vulnerability on the HIV-1 Envelope SpikeNatively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding siteCryo-electron tomography of homophilic adhesion mediated by the neural cell adhesion molecule L1.Climate change and the integrity of scienceLEM2 recruits CHMP7 for ESCRT-mediated nuclear envelope closure in fission yeast and human cells.Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies.Nanogold as a specific marker for electron cryotomographyComputational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residuesEvaluation of CD4-CD4i antibody architectures yields potent, broadly cross-reactive anti-human immunodeficiency virus reagents.Solution structure of choline binding protein A, the major adhesin of Streptococcus pneumoniae.Dimeric 2G12 as a potent protection against HIV-1.Antibody 10-1074 suppresses viremia in HIV-1-infected individuals
P50
Q21090507-BBCC0916-2BDB-4725-B7D8-B129ECD79FB3Q21092776-61EBD0B6-6C64-4E4A-B709-CB7C1BD00842Q21256433-7E23B766-3092-4E25-ACFF-3F7735228194Q24310451-F47819BF-32B2-4742-B50D-06CC7D3425C0Q24631510-87437045-B4E2-493D-BD2F-9391009CFA54Q24655380-A502B890-F909-4986-99AF-DE80A1608778Q24816484-D0E0D95E-4D91-4573-8450-0A3465C062DDQ27320966-285CB195-B96E-4D5D-8356-8A63B36C7B8AQ27330259-E39EB9CF-0E61-4F41-91ED-E4D59B334591Q27331060-B9CA01F6-683D-4A5C-B42F-ED5157AE8BC7Q27331323-80EC0048-0E34-45F4-B4F3-2D273D8D2217Q27641329-A1D5C9D7-3CDB-4D63-8E06-0C57B2CBE9D4Q27641776-C0D00113-44D3-4AB5-8BB8-7D1DB8447119Q27643993-10977E5A-A105-4756-93F1-641C9CF18788Q27644551-57B8F452-399C-4E03-BDC5-0ACD8363A632Q27645220-AA879E78-E423-40C3-8E96-647AF5A07B8EQ27651190-AF4DD367-09C8-4D66-98A1-199740004DD1Q27651216-E5A9369E-545E-48A9-A971-E7A2E436EFFAQ27657836-E0076C8D-40D0-4675-9EE7-A70D8A5666A4Q27660384-0E3AC49D-4DB1-43C4-B164-894B03B87B90Q27665333-E5CE5749-BED3-4C33-80EF-6D2F3CC36FFBQ27670829-81FE3453-2D3F-4795-AAF8-DAABD1A38CD7Q27671182-792E424B-8C89-40BE-B923-51F008CADF8AQ27674878-106A6620-2342-4C14-A957-FDD1511FDDA4Q27677011-583E5895-2C3D-46AC-A219-33B4B20FECD0Q27677117-FBAF800D-A560-4C59-9F8C-19163668F6BFQ27678352-DE20A638-1A95-4707-883C-23E3E1878F3EQ27680810-AEA32F31-AD12-4630-A7B4-DCD141475199Q27683540-7AFC8CB5-77C8-4888-8CE1-34A038BEBC19Q27728037-CC9FC5A0-079E-4D3B-9489-8DC52713FB8DQ27865230-E117FB98-598A-4D8F-82E1-1FAA5CDA846AQ28592187-166bf993-44fa-8192-7cae-0fbb9146c9a4Q29977774-C7CA12FF-0123-4A5D-94C3-8046C8C50947Q30352300-3268D3CD-2004-4BC8-B852-5476B42DA92EQ30492070-BFA62D46-8B62-416A-A92A-ADF7CC58AD65Q30644992-E2ABAB19-5DBA-4185-8FB0-1BE30FEC983BQ33558696-0B0B44CB-62F0-4CEF-9AC6-5AE4446992C5Q33739670-3B61AED2-D286-440A-8D48-89625DEA7803Q33780961-E2B29237-9CEA-4585-967A-A0A83A782D08Q33786443-EF6D7133-39CB-4AA0-9BBB-FA9FA67C7606
P50
description
American biochemist
@en
Amerikaans biochemica
@nl
US-amerikanische Biochemikerin und Molekularbiologin
@de
biocimiciste american
@lfn
bithchemiceoir Meiriceánach
@ga
usona biokemiisto
@eo
name
Pamela Bjorkman
@pt
Pamela J. Bjorkman
@ca
Pamela J. Bjorkman
@cy
Pamela J. Bjorkman
@da
Pamela J. Bjorkman
@de
Pamela J. Bjorkman
@en
Pamela J. Bjorkman
@es
Pamela J. Bjorkman
@fr
Pamela J. Bjorkman
@ga
Pamela J. Bjorkman
@it
type
label
Pamela Bjorkman
@pt
Pamela J. Bjorkman
@ca
Pamela J. Bjorkman
@cy
Pamela J. Bjorkman
@da
Pamela J. Bjorkman
@de
Pamela J. Bjorkman
@en
Pamela J. Bjorkman
@es
Pamela J. Bjorkman
@fr
Pamela J. Bjorkman
@ga
Pamela J. Bjorkman
@it
altLabel
P Bjorkman
@en
P J Bjorkman
@en
P. Bjorkman
@en
P. J. Bjorkman
@en
Pamela Bjorkman
@de
Pamela Bjorkman
@en
Pamela Björkman
@de
Pamela Björkman
@en
Pamela J Bjorkman
@en
Pamela J. Björkman
@de
prefLabel
Pamela Bjorkman
@pt
Pamela J. Bjorkman
@ca
Pamela J. Bjorkman
@cy
Pamela J. Bjorkman
@da
Pamela J. Bjorkman
@de
Pamela J. Bjorkman
@en
Pamela J. Bjorkman
@es
Pamela J. Bjorkman
@fr
Pamela J. Bjorkman
@ga
Pamela J. Bjorkman
@it
P106
P166
P214
P244
P101
P166
P19
P21
P213
0000 0000 3317 7882
P214
P2381
P244
P31
P373
Pamela J. Bjorkman